Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,613 | N/A | -368,496 | -374,499 | -6,355 |
| Depreciation Amortization | 474 | N/A | 173,731 | 172,226 | 433 |
| Income taxes - deferred | N/A | N/A | -172,051 | -180,130 | N/A |
| Accounts receivable | -562 | N/A | N/A | N/A | -407 |
| Accounts payable and accrued liabilities | 187 | N/A | N/A | N/A | -306 |
| Other Working Capital | -1,795 | N/A | 38,554 | 5,623 | 91 |
| Other Operating Activity | 532 | 0 | 338,916 | 337,925 | 880 |
| Operating Cash Flow | $-7,777 | $N/A | $10,654 | $-38,855 | $-5,664 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -94 | N/A | -3,086 | -2,305 | -135 |
| Net Acquisitions | N/A | N/A | 2,250 | 2,250 | N/A |
| Purchase Of Investment | -1,000 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 5,265 | N/A | N/A | N/A | 500 |
| Other Investing Activity | 500 | 0 | -1 | -1 | 19 |
| Investing Cash Flow | $4,671 | $N/A | $-837 | $-56 | $384 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,776 | N/A | N/A | N/A | -857 |
| Common Stock Issued | 14 | N/A | N/A | N/A | 14 |
| Other Financing Activity | 0 | 0 | -25,239 | -17,239 | 1,618 |
| Financing Cash Flow | $-1,762 | $N/A | $-25,239 | $-17,239 | $775 |
| Exchange Rate Effect | 5 | N/A | N/A | N/A | -13 |
| Beginning Cash Position | 34,077 | N/A | 557,352 | 557,352 | 25,018 |
| End Cash Position | 29,231 | N/A | 541,930 | 501,202 | 20,500 |
| Net Cash Flow | $-4,846 | $N/A | $-15,422 | $-56,150 | $-4,518 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,777 | N/A | 10,654 | -38,855 | -5,664 |
| Capital Expenditure | -94 | N/A | -3,086 | -2,305 | -135 |
| Free Cash Flow | -7,871 | 0 | 7,568 | -41,160 | -5,799 |